BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23354601)

  • 1. Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study.
    Dong X; Tao DB; Wang YX; Cao H; Xu YS; Wang QY
    Neurol Sci; 2013 Sep; 34(9):1591-5. PubMed ID: 23354601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke.
    Wang CW; Wang JL; Zhang Y; Li Q; Guo SX; Ji SB
    Neuroreport; 2014 Dec; 25(18):1447-52. PubMed ID: 25383462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes.
    Wang CB; Zong M; Lu SQ; Tian Z
    J Diabetes Complications; 2016; 30(8):1532-1536. PubMed ID: 27554438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma copeptin and long-term outcomes in acute ischemic stroke.
    Zhang JL; Yin CH; Zhang Y; Zhao LB; Fu HJ; Feng JC
    Acta Neurol Scand; 2013 Dec; 128(6):372-80. PubMed ID: 23614762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
    Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
    Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
    Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
    Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of copeptin: one-year outcome in patients with acute stroke.
    Urwyler SA; Schuetz P; Fluri F; Morgenthaler NG; Zweifel C; Bergmann A; Bingisser R; Kappos L; Steck A; Engelter S; Müller B; Christ-Crain M; Katan M
    Stroke; 2010 Jul; 41(7):1564-7. PubMed ID: 20508186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
    De Marchis GM; Katan M; Weck A; Fluri F; Foerch C; Findling O; Schuetz P; Buhl D; El-Koussy M; Gensicke H; Seiler M; Morgenthaler N; Mattle HP; Mueller B; Christ-Crain M; Arnold M
    Neurology; 2013 Apr; 80(14):1278-86. PubMed ID: 23468541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of copeptin in the emergency department as a predictor of adverse outcomes in non-ST-elevation acute coronary syndrome: the COPED-PAO study.
    Sánchez M; Llorens P; Herrero P; Martín-Sanchez FJ; Piñera P; Miró Ò;
    Emerg Med J; 2014 Apr; 31(4):286-91. PubMed ID: 23371977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
    De Marchis GM; Weck A; Audebert H; Benik S; Foerch C; Buhl D; Schuetz P; Jung S; Seiler M; Morgenthaler NG; Mattle HP; Mueller B; Christ-Crain M; Arnold M; Katan M
    Stroke; 2014 Oct; 45(10):2918-23. PubMed ID: 25169950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copeptin and risk stratification in patients with acute dyspnea.
    Potocki M; Breidthardt T; Mueller A; Reichlin T; Socrates T; Arenja N; Reiter M; Morgenthaler NG; Bergmann A; Noveanu M; Buser PT; Mueller C
    Crit Care; 2010; 14(6):R213. PubMed ID: 21106053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copeptin Kinetics in Acute Ischemic Stroke May Differ According to Revascularization Strategies: Pilot Data.
    Spagnolello O; De Michele M; Lorenzano S; Cerulli Irelli E; Naitana F; Falcou A; Letteri F; Bachetoni A; Collepardo D; Bertazzoni G; Toni D
    Stroke; 2019 Dec; 50(12):3632-3635. PubMed ID: 31630623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics.
    Wendt M; Ebinger M; Kunz A; Rozanski M; Waldschmidt C; Weber JE; Winter B; Koch PM; Nolte CH; Hertel S; Ziera T; Audebert HJ;
    Stroke; 2015 Sep; 46(9):2426-31. PubMed ID: 26251255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic role of resistin and copeptin in acute ischemic stroke.
    Perovic E; Mrdjen A; Harapin M; Tesija Kuna A; Simundic AM
    Top Stroke Rehabil; 2017 Dec; 24(8):614-618. PubMed ID: 28845746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 90-day prognostic value of copeptin in acute intracerebral hemorrhage.
    Wei ZJ; Ou YQ; Li X; Li H
    Neurol Sci; 2014 Nov; 35(11):1673-9. PubMed ID: 24798127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies.
    Choi KS; Kim HJ; Chun HJ; Kim JM; Yi HJ; Cheong JH; Kim CH; Oh SJ; Ko Y; Kim YS; Bak KH; Ryu JI; Kim W; Lim T; Ahn HS; Ahn IM; Lee SH
    Sci Rep; 2015 Jun; 5():11665. PubMed ID: 26119473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postsurgical utility of copeptin for the prediction of postoperative arginine vasopressin deficiency.
    Donegan D; Bornhorst J; Van Gompel J; Atkinson J; Theobald JP; Meyer FF; Link MJ; Peris-Celda M; Spears G; Erickson D
    J Neurosurg; 2024 May; 140(5):1276-1284. PubMed ID: 37948691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis.
    Xu Q; Tian Y; Peng H; Li H
    Hypertens Res; 2017 May; 40(5):465-471. PubMed ID: 27904159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
    Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Vafai-Tabrizi F; Gschwantler M; Fasching P; Wojta J; Giannitsis E; Huber K
    Clin Res Cardiol; 2022 Mar; 111(3):343-354. PubMed ID: 34782921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.